Author(s): Fenrich Jon, Vidaurri Vincent
Issue: Sep/Oct 2000 - Compounding for Immune System Disorders
View All Articles in Issue
Page(s): 346
Download in electronic PDF format for $75
Abstract: Psoriasis is a common skin disorder affecting around 2% of the US population. This article provides an overview of its causes, pathogenesis and therapeutic options. The authors end their discussion by suggesting that compounding pharmacists have more comprehensive tools to treat such diseases than those available to the average ambulatory pharmacist and that disseminating knowledge about the use of agents in the compounding armamentarium promotes the quality of life of the psoriatic patient.
Related Keywords:
proliferation, cycloporine
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Psoriasis
Fenrich Jon, Vidaurri Vincent
|
Sep/Oct 2000
Pg. 346
|
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Jones Nat, Carvalho Maria, Branvold-Herr Andrea
|
May/Jun 2017
Pg. 205-211
|
Psoriasis Topical Ointment
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 57
|
Psoriasis Topical Ointment
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 329
|
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
|
Jul/Aug 2018
Pg. 270-278
|
Low-dose Naltrexone Therapy for Psoriasis
Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
|
Mar/Apr 2020
Pg. 94-96
|
Evaluation of the Efficacy and Stability of Compounded Pentoxifylline-containing XemaTop for Psoriasis
Song Guiyun, Ip Kendice, Shan Ashley, Banov Daniel, Bassani August S
|
Jul/Aug 2020
Pg. 337-345
|
Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
|
Sep/Oct 2015
Pg. 357-365
|
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis
Choo Winnie
|
Jan/Feb 2016
Pg. 6-10
|
Treatment Options for Psoriasis
Williams LaVonn A, Humphreys Erica
|
May/Jun 2011
Pg. 204-213
|
Case Reports: Steroid Substitute Treatment for Psoriasis; Metronidazole for Odor Related to Untreated Metastatic Breast Tumor
Mason Dave
|
Jan/Feb 1999
Pg. 34-35
|
Psoriasis Ointment
Allen Loyd V Jr
|
Jul/Aug 1998
Pg. 305
|
Psoriasis Nail Treatment
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 382
|
Psoriasis Ointment, Heavy Moisturizing
Allen Loyd V Jr
|
Sep/Oct 2000
Pg. 383
|
Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride
Zur Eyal
|
Sep/Oct 2011
Pg. 358-366
|
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
|
Mar/Apr 2022
Pg. 94-98
|
Cyclosporine Topical Microemulsion
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 146
|
Tacrolimus 0.1% Topical Microemulsion
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 328
|
Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 419
|
Thioguanine 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 506
|
| Return to Top |
